Skip to content

Clinical Study to Evaluate the Effectiveness of Restosmile Dental Care in Adults with Dentinal Hypersensitivity.

A Prospective, Open-Label, Single-Arm Clinical Study to Evaluate the Effectiveness of a Restosmile Dental Care on Adult Participants with Dentinal Hypersensitivity. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091573
Enrollment
50
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Restosmile Dental Care: A pea-sized amount of the restosmile dental care toothpaste twice daily for a minimum of two minutes per brushing session for 14 days. Control Intervention1: NA:

Sponsors

Aurora Nutraceuticals Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Males and non pregnant or non lactating females between 18 and 70 years of age. 2.Participants with a self reported history of dentinal hypersensitivity. 3.Presence of localized or generalized dentinal hypersensitivity. 4.At least one or two teeth exhibiting sensitivity in response to stimuli. 5.Demonstrate sensitivity to evaporative air stimulus (e.g., Schiff sensitivity score more than or equal to 2). 6.Good general and oral health, with a minimum number of natural teeth (e.g., 20). 7.Willing and able to participate in the study, follow the protocol, and provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Presence of conditions causing pain similar to DH, such as active dental caries, heavily restored or fractured teeth, pulpitis, or extensive loss of periodontal attachment/alveolar bone. 2. Participants with orthodontic or prosthetic appliances that interfere with evaluation. 3. Participants who have used desensitizing treatments (including toothpastes or mouthwashes) or received professional desensitizing procedures within a specified periodprior to baseline (e.g., two weeks to six months). 4. Participants who have undergone vital teeth bleaching within a specified period prior to screening (e.g., two weeks). 5. Participants taking medication that could affect pain perception (e.g., daily analgesics, anti-inflammatory drugs) or antibiotics within a specified period. 6. Participants with a known history of hypersensitivity or allergy to ingredients in the restosmile dental care toothpaste. 7. Participants who consume tobacco or alcohol. 8. Suspected inability or unwillingness to comply with study procedures. 9. Presence of oral processes or habits that keep dentinal tubules exposed, such as poor plaque control, enamel wear, cervical erosion, or incorrect oral hygiene technique. 10. Diagnosis of specific diseases that cause gingival loss, such as necrotizing ulcerative gingivitis (NUG), periodontitis, or herpetic gingivostomatitis. 11. Recent crown preparation that may expose dentinal tubules

Design outcomes

Primary

MeasureTime frame
1.Change in dentinal hypersensitivity from baseline using objective and subjective assessments. 1.1.Thermal Test (Air Blast): Change in Visual Analogue Scale (VAS) score (0 10 scale) and categorical Schiff sensitivity scale. 1.2.Tactile Test: Change in Visual Analogue Scale (VAS) score (0 10 scale)and force in grams (using a Yeaple probe).Timepoint: 1.Screening, Day 07, Day 14. 2.Screening, Day07, Day 14. 3.Screening, Day07, Day 14.

Secondary

MeasureTime frame
1.Daily diary or questionnaire to record the frequency and severity of sensitivity in daily activities. 2.Change in total DHEQ-15 score and scores within each of the five domains (daily functional restrictions, coping behaviours, personal identity, social impact, and emotional impact). 3.Change in overall subjective rating of dentinal hypersensitivity of the entire dentition on a 0-10 scale. 4.Participant feedback will be collected through a structured questionnaire at the end of study.Timepoint: 1.Screening, Day 07, Day 14. 2.Screening, Day07, Day 14. 3.Screening, Day07, Day 14. 4.Day 14.

Countries

India

Contacts

Public ContactMr Purushotam

Auriga Research Private Limited

manojkarwa@aurigaresearch.com09313367656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026